Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02436278
What this trial is testing

The Predictive Ability of 4MGS in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 132
Not applicableStudy completedNCT03068091
What this trial is testing

Assessment of Lung Movement With Computed Tomography (CT)

Who this might be right for
Interstitial Lung Disease
University of Missouri-Columbia 25
Testing effectiveness (Phase 2)Study completedNCT06331624
What this trial is testing

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisIPF
GRI Bio Operations, Inc. 35
Early research (Phase 1)Study completedNCT04767815
What this trial is testing

To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD. 36
Not applicableStudy completedNCT00692796
What this trial is testing

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
National Jewish Health 60
Not applicableStudy completedNCT02594059
What this trial is testing

Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Hopital Foch 43
Early research (Phase 1)Study completedNCT07344558
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Mannkind Corporation 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06422884
What this trial is testing

Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc. 213
Early research (Phase 1)Not Yet RecruitingNCT07515066
What this trial is testing

Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Huan Ye 9
Testing effectiveness (Phase 2)Looking for participantsNCT06325696
What this trial is testing

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
National Institute of Environmental Health Sciences (NIEHS) 37
Not applicableStudy completedNCT04148157
What this trial is testing

Quality of Life in IPF - Patient and Physician Perceptions

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Washington 100
Not applicableStudy completedNCT03770845
What this trial is testing

Nutritional Assessment in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
San Gerardo Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT04552899
What this trial is testing

Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 665
Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1
Very early researchStudy completedNCT03928847
What this trial is testing

Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hal Chapman 35
Not applicableLooking for participantsNCT07723872
What this trial is testing

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more
Hospital de Granollers 100
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Not applicableStudy completedNCT03958071
What this trial is testing

A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 13,264
Not applicableStudy completedNCT03981406
What this trial is testing

Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisDepressionAnxiety+3 more
University of Minnesota 22
Not applicableStudy completedNCT04564664
What this trial is testing

High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Parc de Salut Mar 10
Next Page